Bio Interest Income from 2010 to 2024

BIO Stock

USD 336.09 3.18 0.96%

Bio Rad Interest Income yearly trend continues to be very stable with very little volatility. Interest Income is likely to drop to about 91.6 M. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-03-31

Previous Quarter

16.6 M

Current Value

15.5 M

Quarterly Volatility

1.4 B

Covid

Check Bio Rad financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Rad's main balance sheet or income statement drivers, such as Depreciation And Amortization of 202 M, Interest Expense of 51.9 M or Selling General Administrative of 481.6 M, as well as many indicators such as Price To Sales Ratio of 3.71, Dividend Yield of 0.0 or PTB Ratio of 2.15. Bio financial statements analysis is a perfect complement when working with Bio Rad Valuation or Volatility modules.

Check out the analysis of Bio Rad Correlation against competitors.

Latest Bio Rad's Interest Income Growth Pattern

Below is the plot of the Interest Income of Bio Rad Laboratories over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Bio Rad's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Rad's overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Bio Interest Income Regression Statistics

	Arithmetic Mean	658,110,867
	Geometric Mean	56,223,320
	Coefficient Of Variation	250.10
	Mean Deviation	1,079,615,369
	Median	20,241,000
	Standard Deviation	1,645,930,390
	Sample Variance	2709086.8T
	Range	4.9B
	R-Value	0.33
	Mean Square Error	2596189.7T
	R-Squared	0.11
	Significance	0.23
	Slope	122,135,029
	Total Sum of Squares	37927215.9T

Bio Interest Income History

	2024	91.6 M
	2023	96.4 M
	2022	58 M
	2021	4.9 B
	2020	4.5 B
	2019	30.5 M
	2018	26.6 M

Other Fundumenentals of Bio Rad Laboratories

Net Interest Income

Bio Rad Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Intangible Assets	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Long Term Debt Total	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	0.14	1.0	0.4	0.98	0.69	0.19	-0.12	0.42	-0.37	0.17	-0.15	-0.8	0.67	0.42	0.62	0.99	0.82	0.98	-0.92	0.01	0.96	-0.67	0.4	0.45	0.44	-0.4
Total Stockholder Equity	1.0		0.08	1.0	0.38	0.97	0.65	0.19	-0.12	0.39	-0.35	0.12	-0.18	-0.78	0.67	0.38	0.58	0.98	0.82	0.99	-0.92	-0.04	0.97	-0.67	0.41	0.43	0.4	-0.37
Net Debt	0.14	0.08		0.15	0.05	0.3	0.57	-0.16	-0.24	0.38	-0.07	0.96	0.17	-0.64	-0.13	0.75	0.82	0.2	0.14	0.12	-0.13	0.94	-0.06	-0.18	-0.24	0.45	0.8	-0.72
Retained Earnings	1.0	1.0	0.15		0.34	0.97	0.67	0.19	-0.17	0.39	-0.31	0.18	-0.21	-0.82	0.62	0.44	0.63	0.99	0.81	0.99	-0.9	0.04	0.96	-0.66	0.41	0.46	0.45	-0.42
Net Receivables	0.4	0.38	0.05	0.34		0.46	0.67	0.05	0.47	0.76	-0.88	0.2	0.63	-0.24	0.81	-0.02	0.28	0.3	0.58	0.25	-0.52	-0.09	0.32	-0.33	-0.03	0.26	0.29	0.13
Total Liab	0.98	0.97	0.3	0.97	0.46		0.81	0.18	-0.12	0.52	-0.45	0.35	-0.05	-0.87	0.64	0.5	0.74	0.97	0.82	0.95	-0.91	0.16	0.9	-0.65	0.37	0.53	0.55	-0.48
Total Current Assets	0.69	0.65	0.57	0.67	0.67	0.81		0.15	0.18	0.64	-0.73	0.64	0.3	-0.78	0.59	0.59	0.84	0.68	0.74	0.6	-0.78	0.38	0.49	-0.57	0.22	0.62	0.67	-0.56
Short Term Debt	0.19	0.19	-0.16	0.19	0.05	0.18	0.15		0.29	-0.17	-0.09	-0.29	-0.32	-0.06	0.16	-0.02	0.06	0.18	0.3	0.17	-0.29	-0.35	0.19	0.18	0.68	0.21	-0.15	0.02
Accounts Payable	-0.12	-0.12	-0.24	-0.17	0.47	-0.12	0.18	0.29		-0.13	-0.52	-0.22	0.29	0.28	0.46	-0.22	-0.15	-0.17	0.31	-0.21	-0.2	-0.4	-0.17	-0.2	-0.04	-0.13	-0.25	0.23
Intangible Assets	0.42	0.39	0.38	0.39	0.76	0.52	0.64	-0.17	-0.13		-0.64	0.52	0.67	-0.44	0.52	0.21	0.47	0.36	0.33	0.32	-0.33	0.31	0.33	-0.1	-0.12	0.29	0.53	-0.1
Common Stock	-0.37	-0.35	-0.07	-0.31	-0.88	-0.45	-0.73	-0.09	-0.52	-0.64		-0.22	-0.65	0.18	-0.74	-0.1	-0.26	-0.3	-0.48	-0.24	0.5	0.13	-0.22	0.29	-0.1	-0.15	-0.11	0.1
Long Term Debt	0.17	0.12	0.96	0.18	0.2	0.35	0.64	-0.29	-0.22	0.52	-0.22		0.3	-0.64	-0.06	0.67	0.82	0.22	0.15	0.13	-0.16	0.94	-0.03	-0.24	-0.28	0.48	0.82	-0.64
Good Will	-0.15	-0.18	0.17	-0.21	0.63	-0.05	0.3	-0.32	0.29	0.67	-0.65	0.3		0.17	0.3	-0.04	0.02	-0.21	-0.1	-0.26	0.11	0.1	-0.27	0.12	-0.38	-0.17	0.05	0.08
Treasury Stock	-0.8	-0.78	-0.64	-0.82	-0.24	-0.87	-0.78	-0.06	0.28	-0.44	0.18	-0.64	0.17		-0.32	-0.68	-0.93	-0.84	-0.71	-0.79	0.76	-0.55	-0.7	0.62	-0.22	-0.74	-0.85	0.63
Property Plant Equipment	0.67	0.67	-0.13	0.62	0.81	0.64	0.59	0.16	0.46	0.52	-0.74	-0.06	0.3	-0.32		0.05	0.25	0.59	0.78	0.58	-0.73	-0.33	0.65	-0.55	0.09	0.08	0.14	0.04
Current Deferred Revenue	0.42	0.38	0.75	0.44	-0.02	0.5	0.59	-0.02	-0.22	0.21	-0.1	0.67	-0.04	-0.68	0.05		0.72	0.53	0.39	0.47	-0.36	0.58	0.23	-0.37	0.2	0.45	0.59	-0.95
Short Term Investments	0.62	0.58	0.82	0.63	0.28	0.74	0.84	0.06	-0.15	0.47	-0.26	0.82	0.02	-0.93	0.25	0.72		0.65	0.6	0.58	-0.64	0.72	0.45	-0.53	0.08	0.71	0.89	-0.69
Net Tangible Assets	0.99	0.98	0.2	0.99	0.3	0.97	0.68	0.18	-0.17	0.36	-0.3	0.22	-0.21	-0.84	0.59	0.53	0.65		0.81	0.99	-0.89	0.07	0.94	-0.68	0.43	0.48	0.47	-0.51
Capital Surpluse	0.82	0.82	0.14	0.81	0.58	0.82	0.74	0.3	0.31	0.33	-0.48	0.15	-0.1	-0.71	0.78	0.39	0.6	0.81		0.78	-0.93	-0.05	0.78	-0.77	0.34	0.57	0.5	-0.28
Deferred Long Term Liab	0.98	0.99	0.12	0.99	0.25	0.95	0.6	0.17	-0.21	0.32	-0.24	0.13	-0.26	-0.79	0.58	0.47	0.58	0.99	0.78		-0.87	0.0	0.96	-0.65	0.43	0.42	0.41	-0.45
Accumulated Depreciation	-0.92	-0.92	-0.13	-0.9	-0.52	-0.91	-0.78	-0.29	-0.2	-0.33	0.5	-0.16	0.11	0.76	-0.73	-0.36	-0.64	-0.89	-0.93	-0.87		0.04	-0.84	0.78	-0.4	-0.54	-0.44	0.35
Long Term Debt Total	0.01	-0.04	0.94	0.04	-0.09	0.16	0.38	-0.35	-0.4	0.31	0.13	0.94	0.1	-0.55	-0.33	0.58	0.72	0.07	-0.05	0.0	0.04		-0.13	-0.12	-0.36	0.42	0.79	-0.56
Long Term Investments	0.96	0.97	-0.06	0.96	0.32	0.9	0.49	0.19	-0.17	0.33	-0.22	-0.03	-0.27	-0.7	0.65	0.23	0.45	0.94	0.78	0.96	-0.84	-0.13		-0.61	0.39	0.37	0.34	-0.19
Short Long Term Debt	-0.67	-0.67	-0.18	-0.66	-0.33	-0.65	-0.57	0.18	-0.2	-0.1	0.29	-0.24	0.12	0.62	-0.55	-0.37	-0.53	-0.68	-0.77	-0.65	0.78	-0.12	-0.61		-0.01	-0.39	-0.45	0.35
Cash And Equivalents	0.4	0.41	-0.24	0.41	-0.03	0.37	0.22	0.68	-0.04	-0.12	-0.1	-0.28	-0.38	-0.22	0.09	0.2	0.08	0.43	0.34	0.43	-0.4	-0.36	0.39	-0.01		0.46	-0.1	-0.23
Net Invested Capital	0.45	0.43	0.45	0.46	0.26	0.53	0.62	0.21	-0.13	0.29	-0.15	0.48	-0.17	-0.74	0.08	0.45	0.71	0.48	0.57	0.42	-0.54	0.42	0.37	-0.39	0.46		0.76	-0.37
Net Working Capital	0.44	0.4	0.8	0.45	0.29	0.55	0.67	-0.15	-0.25	0.53	-0.11	0.82	0.05	-0.85	0.14	0.59	0.89	0.47	0.5	0.41	-0.44	0.79	0.34	-0.45	-0.1	0.76		-0.47
Capital Stock	-0.4	-0.37	-0.72	-0.42	0.13	-0.48	-0.56	0.02	0.23	-0.1	0.1	-0.64	0.08	0.63	0.04	-0.95	-0.69	-0.51	-0.28	-0.45	0.35	-0.56	-0.19	0.35	-0.23	-0.37	-0.47

Click cells to compare fundamentals

About Bio Rad Financial Statements

Bio Rad investors utilize fundamental indicators, such as Interest Income, to predict how Bio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Interest Income	96.4 M	91.6 M
Net Interest Income	47.6 M	50 M

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

0.4	VCNX	Vaccinex	Pair Corr
0.4	FBRX	Forte Biosciences Trending	Pair Corr
0.38	VALN	Valneva SE ADR	Pair Corr
0.35	HLN	Haleon plc	Pair Corr

The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.

The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:

How To Invest In Bio

Details

Is Bio Stock a good investment?

Details

What is Bio Rad's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Bio Rad Correlation against competitors.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

5.412

Earnings Share

(28.06)

Revenue Per Share

90.815

Quarterly Revenue Growth

0.028

Return On Assets

0.0186

The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bio Interest Income from 2010 to 2024

Latest Bio Rad's Interest Income Growth Pattern

Bio Interest Income Regression Statistics

Bio Interest Income History

Other Fundumenentals of Bio Rad Laboratories

Bio Rad Interest Income component correlations

About Bio Rad Financial Statements

Pair Trading with Bio Rad

Moving against Bio Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY